Giovanni Ceccarini1, Caterina Pelosini2, Federica Ferrari2, Silvia Magno2, Jacopo Vitti2, Guido Salvetti2, Carlo Moretto3, Antonio Marioni4, Piero Buccianti4, Paolo Piaggi2,5, Margherita Maffei2,6, Ferruccio Santini2. 1. Obesity Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy. giovanni.ceccarini@unipi.it. 2. Obesity Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy. 3. Unit of Bariatric Surgery, University Hospital of Pisa, Pisa, Italy. 4. Unit of Surgery, University Hospital of Pisa, Pisa, Italy. 5. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, United States. 6. Institute of Clinical Physiology, Italian National Research Council, Pisa, Italy.
Abstract
PURPOSE: Expression of IGFBP-2 in mice is regulated by leptin. Over-expression of IGFBP-2 is associated with reduced caloric intake and resistance to weight gain. Hormonal variations contributing to weight loss occur very early after bariatric surgery but have not been fully elucidated. We evaluated IGFBP-2 serum changes after bariatric surgery and their relationship with leptin variations to test the hypothesis that an increase of leptin sensitivity may explain some of the effects of gastric bypass. METHODS: This is a historical prospective study. Fifty-one obese patients (41 women e 10 men), 9 non-obese surgical controls and 41 lean matched controls were studied. Serum IGFBP-2 and leptin were measured after bariatric bypass surgery at various time points up to 18 months, after non-bariatric laparoscopic surgery in a control group, and in lean matched controls. RESULTS: Compared to lean controls, serum IGFBP-2 levels were lower in obese patients. After gastric bypass, IGFBP-2 significantly increased at 3 days and became normal before the occurrence of relevant changes in body weight, remaining stable up to 18 months after surgery. IGFBP-2/leptin ratio increased early after surgery and became normal after one year. CONCLUSIONS: After gastric bypass, serum IGFBP-2 increases in a window of time when variations of hormones mediating the effects of bariatric surgery occur. Our results suggest that IGFBP-2, a leptin-regulated protein, may be an in-vivo marker of leptin action. If this is the case, an early improvement of leptin sensitivity might contribute to the anorectic effect of gastric bypass.
PURPOSE: Expression of IGFBP-2 in mice is regulated by leptin. Over-expression of IGFBP-2 is associated with reduced caloric intake and resistance to weight gain. Hormonal variations contributing to weight loss occur very early after bariatric surgery but have not been fully elucidated. We evaluated IGFBP-2 serum changes after bariatric surgery and their relationship with leptin variations to test the hypothesis that an increase of leptin sensitivity may explain some of the effects of gastric bypass. METHODS: This is a historical prospective study. Fifty-one obesepatients (41 women e 10 men), 9 non-obese surgical controls and 41 lean matched controls were studied. Serum IGFBP-2 and leptin were measured after bariatric bypass surgery at various time points up to 18 months, after non-bariatric laparoscopic surgery in a control group, and in lean matched controls. RESULTS: Compared to lean controls, serum IGFBP-2 levels were lower in obesepatients. After gastric bypass, IGFBP-2 significantly increased at 3 days and became normal before the occurrence of relevant changes in body weight, remaining stable up to 18 months after surgery. IGFBP-2/leptin ratio increased early after surgery and became normal after one year. CONCLUSIONS: After gastric bypass, serum IGFBP-2 increases in a window of time when variations of hormones mediating the effects of bariatric surgery occur. Our results suggest that IGFBP-2, a leptin-regulated protein, may be an in-vivo marker of leptin action. If this is the case, an early improvement of leptin sensitivity might contribute to the anorectic effect of gastric bypass.
Authors: Z Hao; H Münzberg; K Rezai-Zadeh; M Keenan; D Coulon; H Lu; H-R Berthoud; J Ye Journal: Int J Obes (Lond) Date: 2014-10-28 Impact factor: 5.095
Authors: Hatim Boughanem; Elena M Yubero-Serrano; José López-Miranda; Francisco J Tinahones; Manuel Macias-Gonzalez Journal: Int J Mol Sci Date: 2021-01-24 Impact factor: 5.923
Authors: Helene A Fachim; Nagaraj Malipatil; Kirk Siddals; Rachelle Donn; Gabriela Y Cortés; Caroline F Dalton; J Martin Gibson; Adrian H Heald Journal: Epigenomes Date: 2022-02-18
Authors: Jonathan M Dreyfuss; Yixing Yuchi; Xuehong Dong; Vissarion Efthymiou; Hui Pan; Donald C Simonson; Ashley Vernon; Florencia Halperin; Pratik Aryal; Anish Konkar; Yinong Sebastian; Brandon W Higgs; Joseph Grimsby; Cristina M Rondinone; Simon Kasif; Barbara B Kahn; Kathleen Foster; Randy Seeley; Allison Goldfine; Vera Djordjilović; Mary Elizabeth Patti Journal: Nat Commun Date: 2021-11-29 Impact factor: 17.694